Risk of Hypotony in Noninfectious Uveitis

被引:34
作者
Daniel, Ebenezer [1 ,2 ]
Pistilli, Maxwell [1 ,2 ]
Pujari, Siddharth S. [4 ,5 ]
Kacmaz, R. Oktay [4 ,6 ]
Nussenblatt, Robert B. [7 ]
Rosenbaum, James T. [8 ,9 ]
Suhler, Eric B. [8 ,9 ,10 ]
Thorne, Jennifer E. [11 ,12 ]
Foster, C. Stephen [4 ,13 ]
Jabs, Douglas A. [12 ,14 ,15 ]
Levy-Clarke, Grace A. [7 ]
Kempen, John H. [1 ,2 ,3 ]
机构
[1] Univ Penn, Dept Ophthalmol, Ctr Prevent Ophthalmol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[4] Massachusetts Eye Res & Surg Inst, Cambridge, MA USA
[5] Lions Nab Eye Hosp, Miraj, Maharashtra, India
[6] Allergan Pharmaceut Inc, Irvine, CA USA
[7] NEI, Immunol Lab, Bethesda, MD 20892 USA
[8] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA
[9] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA
[10] Portland VA Med Ctr, Portland, OR USA
[11] Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD USA
[12] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
[13] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA
[14] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA
[15] Mt Sinai Sch Med, Dept Med, New York, NY USA
关键词
INTRAOCULAR-LENS IMPLANTATION; OCULAR COMPLICATIONS; CYTOMEGALOVIRUS RETINITIS; ULTRASOUND BIOMICROSCOPY; CYCLODIALYSIS CLEFT; CATARACT-SURGERY; PHACOEMULSIFICATION; PRESSURE; MACULOPATHY; VITRECTOMY;
D O I
10.1016/j.ophtha.2012.05.032
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: We sought to describe the risk and risk factors for hypotony in a noninfectious uveitis cohort. Design: Retrospective cohort study. Participants: Patients with noninfectious uveitis seen between 1979 and 2007 at 4 academic ocular inflammation specialty clinics. Methods: Data were collected from medical records by trained, certified, expert reviewers. Main Outcome Measures: Hypotony (<5 mmHg) and low intraocular pressure (<8 mmHg), each sustained for >= 2 visits spanning >= 30 days. Results: During follow-up, 126 of 6785 patients (1.86%) developed hypotony at the rate of 0.61% (95% confidence interval [CI], 0.50-0.75%) per eye-year. Cataract surgery was associated with a 7.5-fold risk (adjusted hazard ratio [aHR], 7.51; 95% CI, 3.97-14.23) of incident hypotony. Phacoemulsification, the type of cataract surgery associated with the least hypotony risk still was associated with nearly 5-fold higher hypotony incidence (aHR, 4.87; 95% CI, 2.25-10.55). Increased risk was observed in children (aHR, 2.92; 95% CI, 1.20-7.10) with respect to young adults, and duration of uveitis of >5 years (aHR, 3.08; 95% CI, 1.30-7.31) with respect to uveitis of <6 month duration. Band keratopathy, >= 3+ vitreous cells, exudative retinal detachment, posterior synechia, and a history of pars plana vitrectomy also were associated with greater hypotony incidence. With respect to anterior uveitis, intermediate uveitis (aHR, 0.17; 95% CI, 0.05-0.56) and posterior uveitis (aHR, 0.11; 95% CI, 0.03-0.45) were associated with lower hypotony risk, whereas panuveitis (aHR, 1.25; 95% CI, 0.67-2.35) was similar. Approximately five-sixths (84.1%) of eyes presenting with hypotony had a visual acuity of <20/200 (aOR for visual acuity <20/200, 13.85; 95% CI, 7.23-26.53). Risk factors for prevalent hypotony were similar. Conclusions: The risk of hypotony is low among eyes with noninfectious uveitis, but is more frequently observed in cases with anterior segment inflammation. Signs of present or past inflammation were associated with greater risk, suggesting excellent inflammatory control may reduce the risk of hypotony. Prior ocular surgery also was associated with higher risk; cataract surgery in particular was associated with much higher risk of hypotony. Lower risk of hypotony with phacoemulsification than with alternative cataract surgery approaches suggests the phacoemulsification approach is preferable. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references. Ophthalmology 2012; 119: 2377-2385 (C) 2012 by the American Academy of Ophthalmology.
引用
收藏
页码:2377 / 2385
页数:9
相关论文
共 25 条
[1]  
Accorinti M, 2001, OCUL IMMUNOL INFLAMM, V9, P211, DOI 10.1076/ocii.9.3.211.3968
[2]   Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS [J].
Bainbridge, JWB ;
Raina, J ;
Shah, SM ;
Ainsworth, J ;
Pinching, AJ .
EYE, 1999, 13 (3) :353-356
[3]   HYPOTONY AFTER ROTATION OF AN INTRAOCULAR-LENS HAPTIC INTO A CYCLODIALYSIS CLEFT [J].
DAVENPORT, WH ;
BROWN, RH ;
LYNCH, MG .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 101 (06) :736-737
[4]   Risk factors for hypotony maculopathy [J].
Fannin, LA ;
Schiffman, JC ;
Budenz, DL .
OPHTHALMOLOGY, 2003, 110 (06) :1185-1191
[5]  
FLYNN HW, 1988, OPHTHALMOLOGY, V95, P1114
[6]   CATARACT-SURGERY AND INTRAOCULAR-LENS IMPLANTATION IN PATIENTS WITH UVEITIS [J].
FOSTER, CS ;
FONG, LP ;
SINGH, G .
OPHTHALMOLOGY, 1989, 96 (03) :281-287
[8]   TREATING UVEITIS-ASSOCIATED HYPOTONY WITH PARS PLANA VITRECTOMY AND SILICONE OIL INJECTION [J].
Kapur, Rashmi ;
Birnbaum, Andrea D. ;
Goldstein, Debra A. ;
Tessler, Howard H. ;
Shapiro, Michael J. ;
Ulanski, Lawrence J. ;
Blair, Michael P. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (01) :140-145
[9]   Hypotony: An unusual consequence of intraocular lens malposition [J].
Kayikcioglu, O ;
Yagci, A ;
Akkin, C .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1997, 23 (09) :1425-1427
[10]   Methods for identifying long-term adverse effects of treatment in patients with eye diseases: The systemic immunosuppressive therapy for eye diseases (SITE) cohort study [J].
Kempen, John H. ;
Daniel, Ebenezer ;
Gangaputra, Sapna ;
Dreger, Kurt ;
Jabs, Douglas A. ;
Kacmaz, R. Oktay ;
Pujari, Siddharth S. ;
Anzaar, Fahd ;
Foster, C. Stephen ;
Helzlsouer, Kathy J. ;
Levy-Clarke, Grace A. ;
Nussenblatt, Robert B. ;
Llesegang, Teresa ;
Rosenbaum, James T. ;
Suhler, Eric B. .
OPHTHALMIC EPIDEMIOLOGY, 2008, 15 (01) :47-55